Bharat Biotech city New Delhi India covid-19 2020 vaccine Coronavirus Bharat Biotech city New Delhi India

Bharat Biotech begins human dosing of Covid-19 vaccine at AIIMS Patna, PGIMS Rohtak

Reading now: 691
www.livemint.com

NEW DELHI: Human dosing of Bharat Biotech International Ltd’s vaccine candidate ‘covaxin’ against the novel coronavirus started on Wednesday, with the vaccine being given to participants at All India Institute of Medical Sciences, Patna and Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS) at Rohtak in Haryana, a spokesperson for the company said in a statement late Friday.“India’s First Indigenous Covid19 Vaccine Covaxin initiated phase-1 clinical trials across the country on 15th July 2020.

This is a randomised, double-blind, placebo-controlled clinical trial in 375 volunteers in India," a spokesperson for Bharat Biotech said in a statement.AIIMS Patna was the first institute to start the trial on Wednesday.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA